Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine

Polio vaccination: past, present and future

(2015) Ananda S Bandyopadhyay et al.   Future Microbiology

New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication

(2015) Sarah Knowlson et al.   PLoS Pathogens

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative

(2015) Glynis Dunn et al.   PLoS Pathogens

A C-terminal, cysteine-rich site in poliovirus 2CATPase is required for morphogenesis

(2014) C. Wang et al.   JOURNAL OF GENERAL VIROLOGY

Distinct Conformations of a Putative Translocation Element in Poliovirus Polymerase

(2014) Aaron J. Sholders et al.   JOURNAL OF MOLECULAR BIOLOGY

Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants

(2014) Pauline Verdijk et al.   VACCINE

National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication

(2013) Kimberly M Thompson et al.   Expert Review of Vaccines

Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV)

(2013) Kenji Okada et al.   JOURNAL OF INFECTIOUS DISEASES

Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis

(2012) Vaia Pliaka et al.   Expert Review of Vaccines

A plate-based high-throughput assay for virus stability and vaccine formulation

(2012) Thomas S. Walter et al.   JOURNAL OF VIROLOGICAL METHODS

PER.C6® cells as a serum-free suspension cell platform for the production of high titer poliovirus: A potential low cost of goods option for world supply of inactivated poliovirus vaccine

(2012) Barbara P. Sanders et al.   VACCINE

Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled Trial

(2011) Guoyang Liao et al.   JOURNAL OF INFECTIOUS DISEASES

A Host-Specific, Temperature-Sensitive Translation Defect Determines the Attenuation Phenotype of a Human Rhinovirus/Poliovirus Chimera, PV1(RIPO)

(2011) N. Jahan et al.   JOURNAL OF VIROLOGY

Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV

(2011) Wilfried A.M. Bakker et al.   VACCINE

Characterization and standardization of Sabin based inactivated polio vaccine: Proposal for a new antigen unit for inactivated polio vaccines

(2011) Janny Westdijk et al.   VACCINE

Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model

(2009) Bruce Thorley et al.   JOURNAL OF CLINICAL VIROLOGY

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication

(2009) Philip Minor   VACCINE

Engineering attenuated virus vaccines by controlling replication fidelity

(2008) Marco Vignuzzi et al.   NATURE MEDICINE

Virus Attenuation by Genome-Scale Changes in Codon Pair Bias

(2008) J. R. Coleman et al.   SCIENCE